We are cogently aware of the potential residing across the market, and are posed to tap into the long-term value of the European and American cannabis industries.
The global medical cannabis market is growing at a staggering rate. As regulatory frameworks which permits use of medical cannabis through different delivery methods evolve, we provide support across the entire value chain.
The cannabis market in Europe is conservatively calculated to weight XX s Swiss Francs, and shows compound annual growth of 25% from 2021to 2026, driven by the cascading legalization of cannabis flower in a growing number of European markets, plus the positive advent of CBD globally.
We believe that the best is yet to come for cannabis. As Europe steps into continent-wide reforms and approaches legalization, our group’s strategy is simple; be a central player in cannabis, doing so by addressing the medical, recreational, retail, agriculture, extraction, and other industries within the cannabis sector.
We are positioned to pursue an expediated growth strategy, and also geared towards international growth opportunities through our brands and services, our distribution network in Europe and America, and a complete supply chain that includes our production facilities in Switzerland and Canada.
The demand for our products and services is supported by efficient cultivation, processing, and manufacturing facilities. Alpen have developed a rich portfolio of branded cannabis products to strengthen our leadership position.
Finally, we are highly committed to the pursuit of novelty and innovation, which necessitates staying ahead of cannabis regulation and requirements in order to bring the best services to our customers and partners.
